Regardless of how you refer to them, patient education pamphlets or patient education leaflets, there are soon to be some new requirements on these types of patient education materials when the new Meaningful Use Stage II requirements are released. There is some specific language along the lines of, "Patient education materials are to be provided to the patient in their native language." Granted, this is pretty vague, but in order to provide the best treatment and the ensure the best outcome for each patient, this makes sense.
One of our primary goals at Lexicomp is to improve patient outcomes. From providing clinicians the tools they need to make decisions on drug therapy and treatment at the point-of-care to educating patients on the medications they are taking. This all rolls up into better outcomes and decreased costs.
Specific to the new patient education requirements, Lexicomp is one of the only resources that provides high end patient education materials in multiple languages, 19 of the most common languages in the U.S. and Canada in fact. These materials can be integrated into your Health Information System (Epic, for example) and can be used in your hospital's patient portal. They are very versatile and delivered in the appropriate formats to meet multiple needs.
One of our primary goals at Lexicomp is to improve patient outcomes. From providing clinicians the tools they need to make decisions on drug therapy and treatment at the point-of-care to educating patients on the medications they are taking. This all rolls up into better outcomes and decreased costs.
Specific to the new patient education requirements, Lexicomp is one of the only resources that provides high end patient education materials in multiple languages, 19 of the most common languages in the U.S. and Canada in fact. These materials can be integrated into your Health Information System (Epic, for example) and can be used in your hospital's patient portal. They are very versatile and delivered in the appropriate formats to meet multiple needs.
Comments for Patient Education and Meaningful Use Stage II